Startup profile for IDRx: what they do, why they are interesting, stage (acquired), industries, and links to our funding articles. Part of the Venture Capital Tracker startup directory.
Venture Capital Tracker Logo

Venture Capital Tracker

Startup profile · funding coverage

IDRx

IDRx is a precision-oncology biotech developing targeted cancer therapies from the a16z bio portfolio.

Stage

acquired

Status

acquired

Coverage

full

Why IDRx is interesting

Part of the a16z bio wave backing next-gen oncology platforms — public syndicate details beyond a16z are limited in press.

Key facts

  • a16z portfolio status: Exit
  • Co-investors: no additional institutional investors disclosed in public sources reviewed 2026-07-24

Investors in our directory

Funds linked from IDRx's profile — open a fund page for stage focus and related deal articles.

Andreessen Horowitz

Industries

Generalist Technology

Industry hub pages are rolling out from our fund-derived baseline taxonomy.

Related funding articles

Venture Capital Tracker pieces that cover IDRx's financing or category context.

All startups Funding news

Last updated: 2026-07-24